Skip to main content

Aon is a leading global provider of risk management, insurance brokerage, reinsurance brokerage and human resource solutions with 50.000 employees in over 120 countries. We provide our customers with independent advice regarding insurances, reinsurances, risk management, pensions and employee benefits. Aon Belgium is part of Aon plc (NYSE: AON) with headquarters in London.

Aon’s clients range from global corporations to privately held entities. We place approximately $1 billion in premium into the market on behalf of our life sciences clients each year, and we provide risk management and insurance services to 8 out of 10 largest pharma companies and 9 out of the top 10 largest biotech companies.

In Belgium, we are 170 people to perform the industrial risks broking activity on the Belgian market and are by far the largest Life Science broker in Belgium. Our work is thus grounded in a deep understanding of what life science clients need as their organizations grow and mature.

The life sciences sector is undergoing a tremendous amount of change, including a resurgence in key competitive, regulatory and workforce risks. At Aon, we partner with biotechnology, medical device, pharmaceutical and research firms to help them achieve their mission of improving and protecting the lives of patients through our end-to-end solutions in health and benefits, human capital, governance, risk and retirement.

We help life science companies in risk quantification (professional liability, pharmaceutical product liability, clinical trials, directors & officers liability, property, transportation of active pharmaceutical ingredients and many more) and the placement of insurance cover for these risks. We also advise our clients on how and where to obtain the most appropriate clinical trials insurance covers in the various countries where they are performed. We publish a yearly Clinical Trial risk map helping clients conduct and monitor clinical trials worldwide as these trials represent an essential step in the process of regulatory approval and marketing and are critical to the long-term success of any life science company.

Due to our expertise in the industry and partnership with big life science companies all over the world, our proprietary data, technology and advisory services can help you protect your intangible assets against market and environmental volatility and control your total cost of risk through our competitive data-based analysis with industry benchmarks. Our M&A solutions helps our clients to be acquisition and merger ready.

Furthermore, we provide the industry with a yearly risk management survey, highlighting the specific concerns of the life science industry. We help our clients become more risk ready by evaluating and addressing their risk posture.




Bart Van Gysegem – Major Accounts Director and Life Science Practice Leader Belgium

E-mail :

T: +32 (0)2 769.74.03

M: +32 (0)497.44.27.79